Incidence of and risk factors for bacteraemia in HIV-infected adults in the era of highly active antiretroviral therapy

HIV Medicine

Volumn 12, Issue 9, 2011, Pages 535-543

  Yehia, B R ^a   Fleishman, J A ^b   Wilson, L ^c   Hicks, P L ^c   Gborkorquellie, T T ^d   Gebo, K A ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Bacteraemia; Highly active antiretroviral therapy; HIV; Staphylococcus aureus

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; ESCHERICHIA COLI; ETHNICITY; FEMALE; GRAM NEGATIVE BACTERIUM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; RISK FACTOR; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTEREMIA; COHORT STUDIES; FEMALE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; UNSAFE SEX; YOUNG ADULT;

EID: 80053386006     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2011.00919.x     Document Type: Article

References (29)

1. National Center for Health Statistics. Health, United States, 2009: With Special Features on Medical Technology. Hyattsville, MD, 2010.
2. Fichtenbaum CJ, Dunagan WC, Powderly WG. Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 51-57.
3. Mootsikapun P. Bacteremia in adult patients with acquired immunodeficiency syndrome in the northeast of Thailand. Int J Infect Dis 2007; 11: 226-231.
4. Senthilkumar A, Kumar S, Sheagren JN. Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clin Infect Dis 2001; 33: 1412-1416.
5. Meynard JL, Guiguet M, Fonquernie L et al. Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV-infected patients and their epidemiologic characteristics. HIV Med 2003; 4: 127-132.
6. Petrosillo N, Viale P, Nicastri E et al. Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors. Clin Infect Dis 2002; 34: 677-685.
7. Meyer CN, Skinhoj P, Prag J. Bacteremia in HIV-positive and AIDS patients: incidence, species distribution, risk-factors, outcome, and influence of long-term prophylactic antibiotic treatment. Scand J Infect Dis 1994; 26: 635-642.
8. Tumbarello M, Tacconelli E, Donati KG et al. HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era. J Acquir Immune Defic Syndr 2000; 23: 145-151.
9. Tumbarello M, Tacconelli E, Caponera S, Cauda R, Ortona L. The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. J Infect 1995; 31: 123-131.
10. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-317.
11. Tumbarello M, de Gaetano Donati K, Tacconelli E et al. Risk factors and predictors of mortality of methicillin-resistant staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother 2002; 50: 375-382.
12. Burkey MD, Wilson LE, Moore RD, Lucas GM, Francis J, Gebo KA. The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era. HIV Med 2008; 9: 858-862.
13. Hidron AI, Kourbatova EV, Halvosa JS et al. Risk factors for colonization with methicillin-resistant staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis 2005; 41: 159-166.
14. Mathews WC, Caperna JC, Barber RE et al. Incidence of and risk factors for clinically significant methicillin-resistant staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005; 40: 155-160.
15. Skiest DJ, Grant P, Keiser P. Nontunneled central venous catheters in patients with AIDS are associated with a low infection rate. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 220-226.
16. Thorne JE, Jabs DA, Vitale S, Miller T, Dunn JP, Semba RD. Catheter complications in AIDS patients treated for cytomegalovirus retinitis. AIDS 1998; 12: 2321-2327.
17. Wang JT, Sheng WH, Chen MY et al. Nosocomial bloodstream infection in human immunodeficiency virus-infected patients in Taiwan: descriptive epidemiology and risk factors for mortality. J Formos Med Assoc 2004; 103: 743-748.
18. Afessa B, Morales I, Weaver B. Bacteremia in hospitalized patients with human immunodeficiency virus: a prospective, cohort study. BMC Infect Dis 2001; 1: 13.
19. Ortega M, Almela M, Soriano A et al. Bloodstream infections among human immunodeficiency virus-infected adult patients: epidemiology and risk factors for mortality. Eur J Clin Microbiol Infect Dis 2008; 27: 969-976.
20. Hill PC, Onyeama CO, Ikumapayi UN et al. Bacteraemia in patients admitted to an urban hospital in West Africa. BMC Infect Dis 2007; 7: 2.
21. Murphy EL, DeVita D, Liu H et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis 2001; 33: 35-40.
22. Gebo KA, Burkey MD, Lucas GM, Moore RD, Wilson LE. Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 2006; 43: 426-432.
23. Miller M, Cespedes C, Vavagiakis P, Klein RS, Lowy FD. Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis 2003; 22: 463-469.
24. Pan ES, Diep BA, Charlebois ED et al. Population dynamics of nasal strains of methicillin-resistant staphylococcus aureus - and their relation to community-associated disease activity. J Infect Dis 2005; 192: 811-818.
25. Tuazon CU, Sheagren JN. Increased rate of carriage of staphylococcus aureus among narcotic addicts. J Infect Dis 1974; 129: 725-727.
26. McBean M, Rajamani S. Increasing rates of hospitalization due to septicemia in the US elderly population, 1986-1997. J Infect Dis 2001; 183: 596-603.
27. Marrie TJ. Pneumococcal pneumonia: epidemiology and clinical features. Semin Respir Infect 1999; 14: 227-236.
28. Asgeirsson H, Gudlaugsson O, Kristinsson KG, Heiddal S, Kristjansson M. Staphylococcus aureus bacteraemia in Iceland, 1995-2008: changing incidence and mortality. Clin Microbiol Infect 2011; 17: 513-518.
29. Boucher H, Miller LG, Razonable RR. Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2010; 51(Suppl 2): S183-S197.